Thomas Wirth

10.6k total citations · 3 hit papers
122 papers, 8.5k citations indexed

About

Thomas Wirth is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Thomas Wirth has authored 122 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 50 papers in Cancer Research and 47 papers in Immunology. Recurrent topics in Thomas Wirth's work include NF-κB Signaling Pathways (42 papers), Immune Response and Inflammation (22 papers) and Immune Cell Function and Interaction (16 papers). Thomas Wirth is often cited by papers focused on NF-κB Signaling Pathways (42 papers), Immune Response and Inflammation (22 papers) and Immune Cell Function and Interaction (16 papers). Thomas Wirth collaborates with scholars based in Germany, United States and China. Thomas Wirth's co-authors include Bernd Baumann, Hartmut Beug, Margit A. Huber, Norbert Kraut, Ninel Azoitei, Hubert Pehamberger, Stefan Grünert, Andreas Sommer, Alexey Ushmorov and Harald J. Maier and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Thomas Wirth

120 papers receiving 8.4k citations

Hit Papers

NF-κB is essential for epithelial-mesenchymal transition ... 1999 2026 2008 2017 2004 2004 1999 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Wirth Germany 47 4.1k 2.6k 2.5k 2.1k 992 122 8.5k
Brydon L. Bennett United States 35 4.5k 1.1× 3.1k 1.2× 3.0k 1.2× 1.8k 0.8× 510 0.5× 62 8.8k
David L. Boyle United States 48 3.2k 0.8× 1.4k 0.5× 2.3k 0.9× 1.5k 0.7× 393 0.4× 110 7.1k
Hiroshi Yokozaki Japan 62 6.1k 1.5× 1.9k 0.7× 1.7k 0.7× 4.1k 1.9× 1.9k 1.9× 305 12.0k
Shigeki Miyamoto United States 42 5.1k 1.3× 3.9k 1.5× 3.0k 1.2× 2.1k 1.0× 327 0.3× 157 8.8k
Bernd Baumann Germany 39 3.1k 0.8× 1.7k 0.7× 1.2k 0.5× 1.5k 0.7× 280 0.3× 84 5.7k
Yuichi Oike Japan 69 6.5k 1.6× 2.5k 1.0× 1.4k 0.5× 2.2k 1.0× 338 0.3× 211 13.1k
Valery Krizhanovsky Israel 35 4.7k 1.2× 1.2k 0.5× 2.6k 1.0× 1.6k 0.7× 199 0.2× 57 9.9k
Weibo Luo United States 37 4.2k 1.0× 3.3k 1.3× 1.5k 0.6× 1.1k 0.5× 254 0.3× 85 7.4k
Richard Moriggl Austria 57 3.9k 1.0× 1.4k 0.6× 3.5k 1.4× 4.4k 2.1× 919 0.9× 176 10.2k
Sylvain Meloche Canada 54 7.3k 1.8× 1.3k 0.5× 1.4k 0.6× 1.9k 0.9× 543 0.5× 151 10.6k

Countries citing papers authored by Thomas Wirth

Since Specialization
Citations

This map shows the geographic impact of Thomas Wirth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Wirth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Wirth more than expected).

Fields of papers citing papers by Thomas Wirth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Wirth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Wirth. The network helps show where Thomas Wirth may publish in the future.

Co-authorship network of co-authors of Thomas Wirth

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Wirth. A scholar is included among the top collaborators of Thomas Wirth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Wirth. Thomas Wirth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wirth, Thomas, et al.. (2025). Beyond FOXO1: AS1842856 inhibits GSK3 to enhance cytotoxic effects in B-ALL. Blood Advances. 9(14). 3441–3454.
2.
Köenig, Alexander, James B. Reinecke, Kristina Lång, et al.. (2024). 1146MO Interim analysis of CABONEN: A multicenter phase II trial investigating cabozantinib in patients with advanced, low proliferative NEN G3. Annals of Oncology. 35. S752–S752. 1 indexed citations
3.
Baumann, Bernd, et al.. (2023). Accelerated aging in mice with astrocytic redox imbalance as a consequence of SOD2 deletion. Aging Cell. 22(9). 11 indexed citations
4.
Leithäuser, Frank, et al.. (2022). Functional IKK/NF-κB signaling in pancreatic stellate cells is essential to prevent autoimmune pancreatitis. Communications Biology. 5(1). 509–509. 9 indexed citations
5.
Fiedler, Katja, Simon Laban, Marie‐Nicole Theodoraki, et al.. (2022). Differential Requirement of Vav Proteins for Btk-dependent and –Independent Signaling During B Cell Development. Frontiers in Cell and Developmental Biology. 10. 654181–654181. 3 indexed citations
6.
Steiger, Katja, et al.. (2021). Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice. Cancers. 13(18). 4541–4541. 4 indexed citations
7.
Wirth, Thomas, et al.. (2020). Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences. 21(15). 5486–5486. 81 indexed citations
8.
Alami, Najwa Ouali, Diana Wiesner, Jochen H. Weishaupt, et al.. (2020). Multiplexed chemogenetics in astrocytes and motoneurons restore blood–spinal cord barrier in ALS. Life Science Alliance. 3(11). e201900571–e201900571. 24 indexed citations
9.
Lattke, Michael, Stephanie Nadine Reichel, Alireza Abaei, et al.. (2017). Transient IKK2 activation in astrocytes initiates selective non-cell-autonomous neurodegeneration. Molecular Neurodegeneration. 12(1). 16–16. 28 indexed citations
10.
Ushmorov, Alexey & Thomas Wirth. (2017). FOXO in B-cell lymphopoiesis and B cell neoplasia. Seminars in Cancer Biology. 50. 132–141. 24 indexed citations
11.
Guan, Hanfeng, Linka Xie, Thomas Wirth, & Alexey Ushmorov. (2016). Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis. Oncotarget. 7(24). 36854–36864. 7 indexed citations
12.
Schmeißer, Michael J., Bernd Baumann, Gry Fluge Vindedal, et al.. (2012). IκB Kinase/Nuclear Factor κB-Dependent Insulin-Like Growth Factor 2 (Igf2) Expression Regulates Synapse Formation and Spine Maturation via Igf2 Receptor Signaling. Journal of Neuroscience. 32(16). 5688–5703. 120 indexed citations
13.
Guan, Hanfeng, Linka Xie, Frank Leithäuser, et al.. (2010). KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma. Blood. 116(9). 1469–1478. 110 indexed citations
14.
Maier, Harald J., et al.. (2010). NF-κB promotes epithelial–mesenchymal transition, migration and invasion of pancreatic carcinoma cells. Cancer Letters. 295(2). 214–228. 180 indexed citations
15.
Voß, Florian, Frank Fleischer, Dragan Marinković, et al.. (2009). Myc Regulates Embryonic Vascular Permeability and Remodeling. Circulation Research. 104(10). 1151–1159. 22 indexed citations
16.
Palmetshofer, Alois, et al.. (2005). B Cell Hyperresponsiveness and Expansion of Mature Follicular B Cells but Not of Marginal Zone B Cells in NFATc2/c3 Double-Deficient Mice. The Journal of Immunology. 174(8). 4797–4802. 16 indexed citations
17.
Azoitei, Ninel, Thomas Wirth, & Bernd Baumann. (2005). Activation of the IκB kinase complex is sufficient for neuronal differentiation of PC12 cells. Journal of Neurochemistry. 93(6). 1487–1501. 25 indexed citations
19.
Huber, Margit A., Ninel Azoitei, Bernd Baumann, et al.. (2004). NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. Journal of Clinical Investigation. 114(4). 569–581. 734 indexed citations breakdown →
20.
Sharir, Hava, et al.. (1996). Coordinate suppression of myeloma-specific genes and expression of fibroblast-specific genes in myeloma X fibroblast somatic cell hybrids. Somatic Cell and Molecular Genetics. 22(1). 1–20. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026